- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2464EUR$2,789USD£2,149GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2464EUR$2,789USD£2,149GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2464EUR$2,789USD£2,149GBP
- Report
- June 2025
- 150 Pages
Global
From €2384EUR$2,699USD£2,079GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2464EUR$2,789USD£2,149GBP
- Report
- June 2025
- 150 Pages
Global
From €2384EUR$2,699USD£2,079GBP
- Report
- June 2025
- 400 Pages
Global
From €4372EUR$4,949USD£3,813GBP
- Report
- May 2025
- 300 Pages
Global
From €4372EUR$4,949USD£3,813GBP
- Report
- November 2025
- 145 Pages
Global
From €3490EUR$3,950USD£3,043GBP
- Report
- February 2025
- 221 Pages
Global
From €2209EUR$2,500USD£1,926GBP
- Report
- June 2025
- 150 Pages
Global
From €2384EUR$2,699USD£2,079GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2464EUR$2,789USD£2,149GBP
- Report
- June 2025
- 400 Pages
Global
From €4372EUR$4,949USD£3,813GBP
- Report
- June 2025
- 138 Pages
Global
From €3490EUR$3,950USD£3,043GBP
- Report
- January 2025
- 140 Pages
Global
From €3490EUR$3,950USD£3,043GBP
- Report
- October 2025
- 150 Pages
Global
From €3401EUR$3,850USD£2,966GBP
€4285EUR$4,850USD£3,736GBP
- Report
- July 2025
- 150 Pages
Global
From €3401EUR$3,850USD£2,966GBP
€4285EUR$4,850USD£3,736GBP
- Report
- August 2025
- 260 Pages
Global
From €4413EUR$4,995USD£3,848GBP
- Report
- September 2025
- 142 Pages
Global
From €3500EUR$4,244USD£3,159GBP
- Report
- August 2025
- 98 Pages
Global
From €3500EUR$4,244USD£3,159GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more